Intermittent versus on-demand use of a very low calorie diet:: a randomized 2-year clinical trial

被引:43
|
作者
Lantz, H [1 ]
Peltonen, M [1 ]
Ågren, L [1 ]
Torgerson, JS [1 ]
机构
[1] Sahlgrens Univ Hosp, SOS Secretariat, Dept Body Composit & Metab, SE-41345 Gothenburg, Sweden
关键词
body composition; cardiovascular risk factors; obesity; treatment; VLCD; weight maintenance;
D O I
10.1046/j.1365-2796.2003.01131.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To compare two different very low calorie diet (VLCD)-based weight maintenance strategies. Design and setting. A randomized 2-year clinical trial performed at the Department of Body Composition and Metabolism, Sahlgrenska University Hospital, Sweden. Subjects. A total of 334 patients, body mass index (BMI) >30 kg m(-2) , aged 18-60 years. Interventions. All the patients started with 16 VLCD weeks. Subjects in the intermittent group were then scheduled to use VLCD for 2 weeks every third month, whilst patients in the on-demand group were instructed to use VLCD whenever their body weight passed an individualized cut-off level. Irrespective of the treatment group, all the subjects were recommended a hypocaloric diet during VLCD-free periods. Main outcome measures. Changes in body weight, body composition, anthropometric variables and cardiovascular risk factors. Results. Completers in both groups maintained highly significant weight losses after 2 years: 7.0+/-11.0 kg (6.2+/-9.5%) in the intermittent group and 9.1+/-9.7 kg (7.7+/-8.1%) in the on-demand group (P<0.001, ns between groups). Male completers in the on-demand group lost significantly more weight than men in the intermittent group, 14.5+/-11.0 kg vs. 4.0+/-10.5 kg, respectively (P<0.01). Most cardiovascular risk factors improved during the first year, whilst anthropometric measures, insulin, HDL- and LDL-cholesterol were also significantly improved after 2 years of treatment. Conclusion. Clinically significant weight reductions were achieved after 2 years of VLCD-based treatment. The structure of VLCD treatment during the maintenance phase did not affect weight loss in the total study population, whilst male subjects might benefit from the VLCD on-demand strategy.
引用
收藏
页码:463 / 471
页数:9
相关论文
共 40 条
  • [31] Effects of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: a randomized clinical trial
    Goss, Amy M.
    Gower, Barbara
    Soleymani, Taraneh
    Stewart, Mariah
    Pendergrass, May
    Lockhart, Mark
    Krantz, Olivia
    Dowla, Shima
    Bush, Nikki
    Barry, Valene Garr
    Fontaine, Kevin R.
    NUTRITION & METABOLISM, 2020, 17 (01)
  • [32] The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial
    Kato, Kanako
    Suzuki, Kunihiro
    Aoki, Chie
    Sagara, Masaaki
    Niitani, Takafumi
    Wakamatsu, Sho
    Yanagi, Kazunori
    Aso, Yoshimasa
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (08) : 743 - 751
  • [33] Effects of Komouni Formulation (Herbal Product of Persian Medicine) With a Low-Calorie Diet on Cardiometabolic Risk Factors in Overweight and Obese Women: A Triple-Blinded Randomized Clinical Trial
    Aghabeiglooei, Zahra
    Namazi, Nazli
    Karimi, Mehrdad
    Soleymani, Samaneh
    Ayati, Mohammad Hossein
    Rezaeizadeh, Hossein
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (01):
  • [34] Changes of Insulin Resistance and Adipokines Following Supplementation with Glycyrrhiza Glabra L. Extract in Combination with a Low-Calorie Diet in Overweight and Obese Subjects: a Randomized Double Blind Clinical Trial
    Alizadeh, Mohammad
    Namazi, Nazli
    Mirtaheri, Elham
    Sargheini, Nafiseh
    Kheirouri, Sorayya
    ADVANCED PHARMACEUTICAL BULLETIN, 2018, 8 (01) : 123 - 130
  • [35] The (cost) effectiveness of a very low-energy diet intervention with the use of eHealth in patients with type 2 diabetes and obesity: study protocol for a randomised controlled non-inferiority trial (E-diet trial)
    Geurts, Karlijn A. M.
    Ozcan, Behiye
    van Hoek, Mandy
    van de Laar, Roel
    van Teeffelen, Jolande
    van Rosmalen, Joost
    van Rossum, Elisabeth F. C.
    Berk, Kirsten A.
    TRIALS, 2023, 24 (01)
  • [36] The (cost) effectiveness of a very low-energy diet intervention with the use of eHealth in patients with type 2 diabetes and obesity: study protocol for a randomised controlled non-inferiority trial (E-diet trial)
    Karlijn A. M. Geurts
    Behiye Ozcan
    Mandy van Hoek
    Roel van de Laar
    Jolande van Teeffelen
    Joost van Rosmalen
    Elisabeth F. C. van Rossum
    Kirsten A. Berk
    Trials, 24
  • [37] Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial
    Athinarayanan, Shaminie J.
    Adams, Rebecca N.
    Hallberg, Sarah J.
    McKenzie, Amy L.
    Bhanpuri, Nasir H.
    Campbell, Wayne W.
    Volek, Jeff S.
    Phinney, Stephen D.
    McCarter, James P.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [38] Effects of a Very Low-Carbohydrate High-Fat Diet and High-Intensity Interval Training on Visceral Fat Deposition and Cardiorespiratory Fitness in Overfat Individuals: A Randomized Controlled Clinical Trial
    Cipryan, Lukas
    Dostal, Tomas
    Litschmannova, Martina
    Hofmann, Peter
    Maffetone, Philip B.
    Laursen, Paul B.
    FRONTIERS IN NUTRITION, 2021, 8
  • [39] Very Low-Carbohydrate High-Fat Diet Improves Risk Markers for Cardiometabolic Health More Than Exercise in Men and Women With Overfat Constitution: Secondary Analysis of a Randomized Controlled Clinical Trial
    Cipryan, Lukas
    Litschmannova, Martina
    Maffetone, Philip B.
    Plews, Daniel J.
    Dostal, Tomas
    Hofmann, Peter
    Laursen, Paul B.
    FRONTIERS IN NUTRITION, 2022, 9
  • [40] Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial
    Ankersen, Dorit Vedel
    Weimers, Petra
    Bennedsen, Mette
    Haaber, Anne Birgitte
    Fjordside, Eva Lund
    Beber, Moritz Emanuel
    Lieven, Christian
    Saboori, Sanaz
    Vad, Nicolai
    Rannem, Terje
    Marker, Dorte
    Paridaens, Kristine
    Frahm, Suzanne
    Jensen, Lisbeth
    Hansen, Malte Rosager
    Burisch, Johan
    Munkholm, Pia
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (12)